30601 - Progressive Supranuclear Palsy (Answered)

Mr George Howarth
To ask the Secretary of State for Health, what steps his Department is taking to support research into new treatments to relieve symptoms for people with progressive supranuclear palsy.

George Freeman

The Department's National Institute for Health Research (NIHR) welcomes funding applications for research into any aspect of human health, including progressive supranuclear palsy (PSP). These applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and health and care services, value for money and scientific quality. The NIHR is not currently funding any projects relating specifically to new treatments to relieve symptoms for people with PSP.

The NIHR has established the Rare Diseases Translation Research Collaboration (TRC) with an initial investment of £20 million over four years. The TRC provides world-class National Health Service research infrastructure to support fundamental discoveries and translation research on rare diseases.